Fingerprint
Dive into the research topics of 'Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
Victor Sandor, Susan Bakke, Robert W. Robey, Min H. Kang, Mikhail V. Blagosklonny, Richard L. Piekarz, William D. Figg, Antonio Tito Fojo, Susan E. Bates, Eben Tucker, Barry Goldspiel, Jonathon Bender, Rebecca Brooks, Kenneth K. Chan, Stanley P. Balcerzak
Research output: Contribution to journal › Article › peer-review
538
Scopus
citations